AIMC Topic: Herpes Zoster Vaccine

Clear Filters Showing 1 to 3 of 3 articles

Drivers of herpes zoster vaccine hesitancy in adults aged 50 and above: A machine learning approach.

Vaccine Oct 12, 2025
BACKGROUND: Herpes zoster (HZ) poses a growing public health challenge among adults aged 50 and above, with vaccine hesitancy being a major barrier to improving immunization rates. Understanding the factors driving HZ vaccine hesitancy is essential f...
Humans Machine Learning Female Aged Aged, 80 and over Cross-Sectional Studies Male Middle Aged China Vaccination Health Knowledge, Attitudes, Practice Herpes Zoster Herpes Zoster Vaccine Health Literacy Vaccination Hesitancy
View on PubMed DOI

Statistical Learning Methods to Determine Immune Correlates of Herpes Zoster in Vaccine Efficacy Trials.

The Journal of infectious diseases Sep 22, 2018
Using Super Learner, a machine learning statistical method, we assessed varicella zoster virus-specific glycoprotein-based enzyme-linked immunosorbent assay (gpELISA) antibody titer as an individual-level signature of herpes zoster (HZ) risk in the Z...
Humans Machine Learning Female Male Middle Aged Case-Control Studies ROC Curve Antibodies, Viral Models, Statistical Randomized Controlled Trials as Topic Area Under Curve Data Interpretation, Statistical Herpes Zoster Herpes Zoster Vaccine
View on PubMed DOI

Immunogenicity, Safety, and Tolerability of Live Attenuated VaricellaZoster Virus Vaccine (ZOSTAVAX™) in Healthy Adults in India.

The Journal of the Association of Physicians of India Jul 1, 2018
BACKGROUND: Herpes zoster (HZ) is caused by varicella-zoster virus ( VZV ) reactivation. In the United States, Zoster vaccine (ZOSTAVAX) is indicated for HZ prevention in patients ≥50 years.
Humans Adult Middle Aged India Antibodies, Viral Herpes Zoster Herpesvirus 3, Human Herpes Zoster Vaccine
View on PubMed
Popular Topics
Recent Journals